The outcome of combine radioligand and CAPTEM therapy in patients with advanced, unresectable, progressive GEP-NET

Category Primary study
JournalAnnals of Oncology
Year 2023
This article has no abstract
Epistemonikos ID: 366ccbebf148a2f2e725d7b7be7fac00d683b798
First added on: Feb 16, 2025